Abstract:Background The disease burden from ischaemic heart disease remains heavy in the Chinese population. Traditional risk scores for estimating long-term mortality in patients with acute myocardial infarction (AMI) have been developed without sufficiently considering advances in interventional procedures and medication. The goal of this study was to develop a risk score comprising clinical parameters and intervention advances at hospital admission to assess 5-year mortality in AMI patients in a Chinese population. Methods We performed a retrospective observational study on 2,722 AMI patients between January 2013 and December 2017. Of these patients, 1,471 patients from Changsha city, Hunan Province, China were assigned to the development cohort, and 1,251 patients from Xiangtan city, Hunan Province, China, were assigned to the validation cohort. Forty-five candidate variables assessed at admission were screened using least absolute shrinkage and selection operator, stepwise backward regression, and Cox regression methods to construct the C2ABS2-GLPK score, which was graded and stratified using a nomogram and X-tile. The score was internally and externally validated. The C-statistic and Hosmer-Lemeshow test were used to assess discrimination and calibration, respectively. Results From the 45 candidate variables obtained at admission, 10 potential predictors, namely, including C reatinine, experience of C ardiac arrest, A ge, N-terminal Pro- B rain Natriuretic Peptide, a history of S troke, S tatins therapy, fasting blood G lucose, L eft ventricular end-diastolic diameter, P ercutaneous coronary intervention and K illip classification were identified as having a close association with 5-year mortality in patients with AMI and collectively termed the C2ABS2-GLPK score. The score had good discrimination (C-statistic = 0.811, 95% confidence intervals (CI) [0.786–0.836]) and calibration (calibration slope = 0.988) in the development cohort. In the external validation cohort, the score performed well in both discrimination (C-statistic = 0.787, 95% CI [0.756–0.818]) and calibration (calibration slope = 0.976). The patients were stratified into low- (≤148), medium- (149 to 218) and high-risk (≥219) categories according to the C2ABS2-GLPK score. The predictive performance of the score was also validated in all subpopulations of both cohorts. Conclusion The C2ABS2-GLPK score is a Chinese population-based risk assessment tool to predict 5-year mortality in AMI patients based on 10 variables that are routinely assessed at admission. This score can assist physicians in stratifying high-risk patients and optimizing emergency medical interventions to improve long-term survival in patients with AMI.

A Novel Broadly Applicable Risk Score for Predicting Mortality of Patients with Circulatory System Diseases Within Hospitalization Duration

[Study on the Efficiency of the European System for Cardiac Operative Risk Evaluation (euroscore) in Predicting In-Hospital Mortality of the Patients with Percutaneous Coronary Intervention].

Building a Patient-Specific Risk Score with a Large Database of Discharge Summary Reports.

A novel risk score for in-hospital perioperative mortality of five major surgeries

Development and validation of a novel risk score to predict 5-year mortality in patients with acute myocardial infarction in China: a retrospective study

Development and Validation of a Sepsis Mortality Risk Score for Sepsis-3 Patients in Intensive Care Unit

A Multifactor Model for Predicting Mortality in Critically Ill Patients: A Multicenter Prospective Cohort Study

Development and Validation of a Risk Score for Predicting 1-Year Mortality Risk of STEMI Based on a Nationwide Cohort in China

New Prognostic Risk Score for Predicting In-Hospital Mortality in Geriatric Patients Undergoing Colorectal Cancer Surgery: U.S. Nationwide Inpatient Sample Analysis

Predicting In-Hospital Mortality in Patients with Acute Coronary Syndrome in China.

E0443 A New 30-Day Mortality Risk Score System for Patients Hospitalised with Acute Myocardial Infarction

A biomarker-based age, biomarkers, clinical history, sex (ABCS)-mortality risk score for patients with coronavirus disease 2019

A Novel Risk Score to Predict In-Hospital Mortality in Patients With Acute Myocardial Infarction: Results From a Prospective Observational Cohort

Predicting the risk of 1-year mortality among patients hospitalized for acute heart failure in China

Establishment of a Novel Risk Score for In-Hospital Mortality in Adult Sepsis Patients

The role of the atrio-ventricular junction in arrhythmias of the human heart.

A simple clinical risk score (ABCDMP) for predicting mortality in patients with AECOPD and cardiovascular diseases

Machine learning-based in-hospital mortality risk prediction tool for intensive care unit patients with heart failure

Development of a Risk Score for Predicting One-Year Mortality in Patients with Atrial Fibrillation Using XGBoost-assisted Feature Selection.

Using machine learning tools to predict outcomes for emergency department intensive care unit patients

A machine learning-based risk stratification tool for in-hospital mortality of intensive care unit patients with heart failure